Plus Therapeutics | CYTX - Net Income

Stock Price
5.64
Daily Change
0.21 3.87%
Monthly
-13.46%
Yearly
-66.41%
Q2 Forecast
4.67

Plus Therapeutics reported $-5.71M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Baxter International USD -1.13B 1.08B Dec/2025
Cerus USD -20.92M 17.98M Dec/2024
Dr.Reddys Laboratories INR 12.1B 2.27B Dec/2025
Haemonetics USD 44.74M 6.06M Dec/2025
Infinity Pharmaceuticals USD -9.96M 1.09M Jun/2023
Northwest Biotherapeutics USD -27.18M 7.81M Sep/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Sanofi EUR -801M 3.6B Dec/2025
Starpharma Holdings AUD 1.37M 3.67M Dec/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025